TLDR: Cornell University’s Ignite Fellow for New Ventures program has selected three groundbreaking research projects for funding and training in 2025. These projects, which include a novel treatment for childhood ear infections, an AI-powered tool for database linking, and an advanced gene editing method, aim to transform university research into marketable products and new ventures that benefit society. The program, managed by Cornell’s Center for Technology Licensing (CTL), supports researchers in developing entrepreneurial skills and accelerating their discoveries from the lab to the market.
Cornell University’s commitment to translating cutting-edge research into tangible societal benefits is once again highlighted through its Ignite Fellow for New Ventures program. For 2025, the program has selected three innovative research projects, providing them with crucial funding and comprehensive training to facilitate their journey from laboratory discovery to market impact. This initiative, overseen by Cornell’s Center for Technology Licensing (CTL), is designed to empower researchers with the entrepreneurial acumen needed to launch successful startups based on their scientific breakthroughs.
The three selected projects represent diverse fields with significant potential for real-world application:
1. Middle Ear Immune Therapy: Led by Fellow Wenjing Tang, a Postdoctoral Associate, and Faculty Rong Yang, Associate Professor at R.F. Smith School of Chemical and Biomolecular Engineering, this project addresses the pervasive issue of childhood ear infections. Traditional oral antibiotic treatments often lead to side effects and contribute to antibiotic resistance. This new method aims to deliver antibiotics directly and non-invasively into the middle ear using specially designed particles, targeting the infection site with a single dosage. The goal is a safer, more effective treatment with fewer systemic side effects and no negative impact on auditory function. Professor Yang previously received Cornell’s Ignite Innovation Acceleration funding in 2024, which helped advance the early-stage research towards commercialization.
2. AI-Powered Database Linking Tool: This project focuses on developing an artificial intelligence-powered tool designed to link disparate databases. While specific details about the fellow and faculty for this project are not explicitly mentioned in the provided search result, its inclusion underscores Cornell’s embrace of AI as a transformative technology for various applications, including data management and integration. This tool has the potential to streamline data analysis and improve efficiency across numerous sectors.
3. Novel Gene Editing Method for Therapeutics: This project, led by Fellow Kyle Peters, a Postdoctoral Associate, and Faculty John T. Lis, Professor of Molecular Biology and Genetics, is developing a new gene editing method. This advanced technology holds promise for more effective treatments for genetic diseases, improved cancer therapies, and significant advancements in biotechnology and agriculture. Peters also received Ignite Innovation Acceleration funds in both 2024 and 2025, which were instrumental in pursuing venture creation for this technology.
Alice Li, Executive Director at CTL, emphasized the program’s core mission, stating, “Cornell researchers are dedicated to tackling critical problems for the greater good. This program accelerates their way into society where they can truly make a difference.” She further highlighted the dual benefit for the fellows: “One of the strengths of the Ignite Fellow program is its focus on supporting the people behind these innovations. These awardees are not only pushing the frontiers of science and engineering but also gaining the entrepreneurial skills they need to bring their work to market.”
Since its inception in 2022, the Ignite Fellow for New Ventures program has provided support to 15 research-based projects, with six startups already having successfully graduated. The program anticipates more projects transitioning into new ventures in the coming months, further enriching Cornell’s venture ecosystem. Each selected project receives approximately $120,000 annually to cover the fellow’s compensation and basic experimental expenses. Fellows are full-time Cornell employees during the program, working in the faculty inventor’s lab for technology development while also having access to incubators for business development. The financial support is structured as the principle of a SAFE note, executed by the startup company upon its establishment.
Also Read:
- Artificial Intelligence and Generative AI Driving Transformative Growth in Healthcare Sector
- PhnyX Lab Secures $4 Million in Seed Funding, Led by SK Networks, to Advance AI in Life Sciences
The Ignite Fellow for New Ventures is one of four signature Ignite programs offered by CTL, all aimed at bridging the gap between academic discovery and market readiness, fostering a robust environment for innovation and entrepreneurship at Cornell University. As Kyle Peters noted, “Becoming an entrepreneur is not just about starting a company, it is about creating a vehicle for innovation that has the potential to change lives.” This sentiment encapsulates the transformative potential of the Ignite program in bringing groundbreaking research to the forefront of societal impact.
